Cleared Traditional

K800935 - R2 APEX-POST.,ANT.&POST. ELECT.(12 MODS)

K800935 is an FDA 510(k) clearance for R2 APEX-POST., manufactured by R2 Corp.. The device is a Class 2 Cardiovascular device with product code DRX cleared through the Traditional 510(k) pathway after a 32-day FDA review.

Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
May 1980
Decision
32d
Days
Class 2
Risk

K800935 is an FDA 510(k) clearance for the R2 APEX-POST.,ANT.&POST. ELECT.(12 MODS). Classified as Electrode, Electrocardiograph (product code DRX), Class II - Special Controls.

Submitted by R2 Corp. (Walker, US). The FDA issued a Cleared decision on May 23, 1980 after a review of 32 days - a notably fast clearance cycle.

This device falls under the Cardiovascular FDA review panel, regulated under 21 CFR 870.2360 - the FDA cardiovascular device oversight framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Fast-track predicate clearance. Standard predicate reliance. The short review cycle indicates strong predicate alignment - the FDA found sufficient equivalence without extended technical review.

FDA 510(k) Submission Details - K800935

510(k) Number K800935 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received April 21, 1980
Decision Date May 23, 1980
Days to Decision 32 days
Submission Type Traditional
Review Panel Cardiovascular (CV)
Summary -
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
93d faster than avg
Panel avg: 125d · This submission: 32d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

DRX Device Classification - Class 2, Special Controls

Product Code DRX Electrode, Electrocardiograph
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 870.2360
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Cardiovascular devices follow this clearance model.

Regulatory Peers - DRX Electrode, Electrocardiograph

All 328
Devices cleared under the same product code (DRX) and FDA review panel - the closest regulatory comparables to K800935.
EXTERNAL JUGULAR CVP CATHERIZATION KIT
K802576 · Willson · Nov 1980
ELECTROCARDIOGRAPH ELECTRODE
K801846 · Phoenix Glove Co. · Sep 1980
R2(TM) ECG ELECTRODE SET-#'S305-306 ETC.
K800930 · R2 Corp. · May 1980
ESOPHAGEAL PILL-ELECTRODE
K800201 · Arzbaecher & Co. · Feb 1980
VXTRA BACK PACK EKG ELECTRODE CAT. NO.
K792436 · Vxtra Corp. · Feb 1980
BARD BIOMEDICAL PRINTED SILVER ELECTRODE
K792040 · C.R. Bard, Inc. · Nov 1979